Functional regulation of T lymphocytes by modulatory extracellular matrix proteins

International Journal of Biochemistry and Cell Biology

Volumn 36, Issue 6, 2004, Pages 1126-1134

  Kuznetsova, Svetlana A ^a   Roberts, David D ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

CCN; Connective tissue growth factor; CTGF; Cysteine rich 61 connective tissue growth factor nephroblastoma overexpressed; ECM; Extracellular matrix; Heparan sulfate proteoglycan; HSPG; Secreted protein acidic and rich in cysteine; SPARC; TCR

Indexed keywords

CONNECTIVE TISSUE GROWTH FACTOR; CYSTEINE; OSTEONECTIN; OSTEOPONTIN; SCLEROPROTEIN; TENASCIN; THROMBOSPONDIN 1; THROMBOSPONDIN 2;

CELL FATE; CELL MATURATION; HUMAN; NEPHROBLASTOMA; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN MODIFICATION; PROTEIN SECRETION; PROTEIN STRUCTURE; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE; TRANSGENIC MOUSE;

ANIMALIA; MUS MUSCULUS;

EID: 14844359865     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biocel.2003.12.006     Document Type: Short Survey

References (69)

1. Adams J.C. Thrombospondins: Multifunctional regulators of cell interactions. Annual Review of Cell and Developmental Biology. 17:2001;25-51.
2. Adams M., Jones J.L., Walker R.A., Pringle J.H., Bell S.C. Changes in tenascin-C isoform expression in invasive and preinvasive breast disease. Cancer Research. 62:2002;3289-3297.
3. Amin K., Ludviksdottir D., Janson C., Nettelbladt O., Gudbjornsson B., Valtysdottir S., Bjornsson E., Roomans G.M., Boman G., Seveus L., Venge P. Inflammation and structural changes in the airways of patients with primary Sjogren's syndrome. Respiration Medicine. 95:2001;904-910.
4. Arroyo A.G., Taverna D., Whittaker C.A., Strauch U.G., Bader B.L., Rayburn H., Crowley D., Parker C.M., Hynes R.O. In vivo roles of integrins during leukocyte development and traffic: Insights from the analysis of mice chimeric for α5, αv, and α4 integrins. J. Immunol. 165:2000;4667-4675.
5. Asadullah K., Volk H.D., Sterry W. Novel immunotherapies for psoriasis. Trends in Immunology. 23:2002;47-53.
6. Ashkar S., Weber G.F., Panoutsakopoulou V., Sanchirico M.E., Jansson M., Zawaideh S., Rittling S.R., Denhardt D.T., Glimcher M.J., Cantor H. Eta-1 (osteopontin): An early component of type-1 (cell-mediated) immunity. Science. 287:2000;860-864.
7. Avice M.N., Rubio M., Sergerie M., Delespesse G., Sarfati M. CD47 ligation selectively inhibits the development of human naive T cells into Th1 effectors. Journal of Immunology. 165:2000;4624-4631.
8. Barazi H.O., Li Z., Cashel J.A., Krutzsch H.C., Annis D.S., Mosher D.F., Roberts D.D. Regulation of integrin function by CD47 ligands. Differential effects on alpha vbeta 3 and alpha 4beta1 integrin-mediated adhesion. The Journal of Biological Chemistry. 277:2002;42859-42866.
9. Beppu R., Nakamura K., Miyajima-Uchida H., Kuroki M., Khare P.D., Yamauchi Y., Yamashita Y., Shirakusa T. Soluble thrombospondin-1 suppresses T cell proliferation and enhances IL-10 secretion by antigen presenting cells stimulated with phytohemagglutinin. Immunological Investigations. 30:2001;143-156.
10. Blom T., Franzen A., Heinegard D., Holmdahl R. Comment on "the influence of the proinflammatory cytokine, osteopontin, on autoimmune demyelinating disease" Science. 299:2003;1845. (author reply 1845).
11. Bornstein P., Sage E. Matricellular proteins: Extracellular modulators of cell function. Current Opinion in Cell Biology. 14:2002;608.
12. Bradshaw A.D., Sage E.H. Sparc, a matricellular protein that functions in cellular differentiation and tissue response to injury. Journal of Clinical Investigation. 107:2001;1049-1054.
13. Brigstock D.R. The ccn family: A new stimulus package. Journal of Endocrinology. 178:2003;169-175.
14. Brown E.J., Frazier W.A. Integrin-associated protein (cd47) and its ligands. Trends in Cell Biology. 11:2001;130-135.
15. Chabas D., Baranzini S.E., Mitchell D., Bernard C.C., Rittling S.R., Denhardt D.T., Sobel R.A., Lock C., Karpuj M., Pedotti R., Heller R., Oksenberg J.R., Steinman L. The influence of the proinflammatory cytokine, osteopontin, on autoimmune demyelinating disease. Science. 294:2001;1731-1735.
16. Chiocchetti, A., Indelicato, M., Bensi, T., Mesturini, R., Giordano, M., Sametti, S., Castelli, L., Bottarel, F., Mazzarino, M.C., Garbarini, L., Giacopelli, F., Valesini, G., Santoro, C., Dianzani, I., Ramenghi, U., Dianzani, U. (2003). High levels of osteopontin associated to polymorphisms in its gene are a risk factor for development of autoimmunity/lymphoproliferation, Blood.
17. Chiquet-Ehrismann R., Chiquet M. Tenascins: Regulation and putative functions during pathological stress. Journal of Pathology. 200:2003;488-499.
18. Clark R.A., Erickson H.P., Springer T.A. Tenascin supports lymphocyte rolling. Journal of Cell Biology. 137:1997;755-765.
19. Demeure C.E., Tanaka H., Mateo V., Rubio M., Delespesse G., Sarfati M. Cd47 engagement inhibits cytokine production and maturation of human dendritic cells. Journal of Immunology. 164:2000;2193-2199.
20. Denhardt D.T., Noda M., O'Regan A.W., Pavlin D., Berman J.S. Osteopontin as a means to cope with environmental insults: Regulation of inflammation, tissue remodeling, and cell survival. Journal of Clinical Investigation. 107:2001;1055-1061.
21. Denton C.P., Abraham D.J. Transforming growth factor-beta and connective tissue growth factor: Key cytokines in scleroderma pathogenesis. Current Opinion in Rheumatology. 13:2001;505-511.
22. Doyen V., Rubio M., Braun D., Nakajima T., Abe J., Saito H., Delespesse G., Sarfati M. Thrombospondin 1 is an autocrine negative regulator of human dendritic cell activation. The Journal of Experimental Medicine. 198:2003;1277-1283.
23. Dustin M.L., de Fougerolles A.R. Reprogramming T cells: The role of extracellular matrix in coordination of T cell activation and migration. Current Opinion in Immunology. 13:2001;286-290.
24. Fisher L.W., Torchia D.A., Fohr B., Young M.F., Fedarko N.S. Flexible structures of sibling proteins, bone sialoprotein, and osteopontin. Biochemical and Biophysical Research Communication. 280:2001;460-465.
25. Freitas C.S., Lyra J.S., Dalmau S.R., Savino W. In vivo and in vitro expression of tenascin by human thymic microenvironmental cells. Developmental Immunology. 4:1995;139-147.
26. Friedl P., Brocker E.B. T cell migration in three-dimensional extracellular matrix: Guidance by polarity and sensations. Developmental Immunology. 7:2000;249-266.
27. Gotis-Graham I., Hogg P.J., McNeil H.P. Significant correlation between thrombospondin 1 and serine proteinase expression in rheumatoid synovium. Arthritis and Rheumatism. 40:1997;1780-1787.
28. Gravallese E.M. Osteopontin: A bridge between bone and the immune system. Journal of Clinical Investigation. 112:2003;147-149.
29. Hauzenberger D., Olivier P., Gundersen D., Ruegg C. Tenascin-C inhibits beta1 integrin-dependent t lymphocyte adhesion to fibronectin through the binding of its fniii 1-5 repeats to fibronectin. European Journal Immunology. 29:1999;1435-1447.
30. Hensiek A.E., Roxburgh R., Meranian M., Seaman S., Yeo T., Compston D.A., Sawcer S.J. Osteopontin gene and clinical severity of multiple sclerosis. Journal of Neurology. 250:2003;943-947.
31. Hibino S., Kato K., Kudoh S., Yagita H., Okumura K. Tenascin suppresses CD3-mediated T cell activation. Biochemical and Biophysical Research Communication. 250:1998;119-124.
32. Hynes R.O. Integrins: Bidirectional, allosteric signaling machines. Cell. 110:2002;673-687.
33. Ivkovic S., Yoon B.S., Popoff S.N., Safadi F.F., Libuda D.E., Stephenson R.C., Daluiski A., Lyons K.M. Connective tissue growth factor coordinates chondrogenesis and angiogenesis during skeletal development. Development. 130:2003;2779-2791.
34. Jansson M., Panoutsakopoulou V., Baker J., Klein L., Cantor H. Cutting edge: Attenuated experimental autoimmune encephalomyelitis in eta-1/osteopontin-deficient mice. Journal of Immunology. 168:2002;2096-2099.
35. Jones F.S., Jones P.L. The tenascin family of ecm glycoproteins: Structure, function, and regulation during embryonic development and tissue remodeling. Developmental Dynamics. 218:2000;235-259.
36. Kaldjian E.P., Gretz J.E., Anderson A.O., Shi Y., Shaw S. Spatial and molecular organization of lymph node T cell cortex: A labyrinthine cavity bounded by an epithelium-like monolayer of fibroblastic reticular cells anchored to basement membrane-like extracellular matrix. International Immunology. 13:2001;1243-1253.
37. Karjalainen E.M., Lindqvist A., Laitinen L.A., Kava T., Altraja A., Halme M., Laitinen A. Airway inflammation and basement membrane tenascin in newly diagnosed atopic and nonatopic asthma. Respiration Medicine. 97:2003;1045-1051.
38. Koch A.E., Friedman J., Burrows J.C., Haines G.K., Bouck N.P. Localization of the angiogenesis inhibitor thrombospondin in human synovial tissues. Pathobiology. 61:1993;1-6.
39. Koguchi Y., Kawakami K., Uezu K., Fukushima K., Kon S., Maeda M., Nakamoto A., Owan I., Kuba M., Kudeken N., Azuma M., Yara S., Shinzato T., Higa F., Tateyama M., Kadota J., Mukae H., Kohno S., Uede T., Saito A. High plasma osteopontin level and its relationship with interleukin-12-mediated type 1 T helper cell response in tuberculosis. American Journal of Respiratory and Critical Care Medicine. 167:2003;1355-1359.
40. Lawler J., Sunday M., Thibert V., Duquette M., George E.L., Rayburn H., Hynes R.O. Thrombospondin-1 is required for normal murine pulmonary homeostasis and its absence causes pneumonia. Journal of Clinical Investigation. 101:1998;982-992.
41. Lawler J. Thrombospondin-1 as an endogenous inhibitor of angiogenesis and tumor growth. Journal of Cellular Molecular Medicine. 6:2002;1-12.
42. Li Z., Calzada M.J., Sipes J.M., Cashel J.A., Krutzsch H.C., Annis D., Mosher D.F., Roberts D.D. Interactions of thrombospondins with α4β1 integrin and CD47 differentially modulate T cell behavior. Journal of Cell Biology. 157:2002;509-519.
43. Li S.S., Ivanoff A., Bergstrom S.E., Sandstrom A., Christensson B., van Nerven J., Holgersson J., Hauzenberger D., Arencibia I., Sundqvist K.G. T lymphocyte expression of thrombospondin-1 and adhesion to extracellular matrix components. European Journal of Immunology. 32:2002;1069-1079.
44. Li Z., He L., Wilson K.E., Roberts D.D. Thrombospondin-1 inhibits tcr-mediated T lymphocyte early activation. Journal of Immunology. 166:2001;2427-2436.
45. Lindberg F.P., Bullard D.C., Caver T.E., Gresham H.D., Beaudet A.L., Brown E.J. Decreased resistance to bacterial infection and granulocyte defects in IAP-deficient mice. Science. 274:1996;795-798.
46. Mo F.E., Muntean A.G., Chen C.C., Stolz D.B., Watkins S.C., Lau L.F. Cyr61 (CCN1) is essential for placental development and vascular integrity. Molecular and Cellular Biology. 22:2002;8709-8720.
47. Nagai S., Hashimoto S., Yamashita T., Toyoda N., Satoh T., Suzuki T., Matsushima K. Comprehensive gene expression profile of human activated T(h)1- and T(h)2-polarized cells. International Immunology. 13:2001;367-376.
48. Nakao N., Hiraiwa N., Yoshiki A., Ike F., Kusakabe M. Tenascin-C promotes healing of habu-snake venom-induced glomerulonephritis: Studies in knockout congenic mice and in culture. American Journal of Pathology. 152:1998;1237-1245.
49. Nickoloff B.J., Mitra R.S., Varani J., Dixit V.M., Polverini P.J. Aberrant production of interleukin-8 and thrombospondin-1 by psoriatic keratinocytes mediates angiogenesis. American Journal of Pathology. 144:1994;820-828.
50. Niino M., Kikuchi S., Fukazawa T., Yabe I., Tashiro K. Genetic polymorphisms of osteopontin in association with multiple sclerosis in japanese patients. Journal of Neuroimmunology. 136:2003;125-129.
51. O'Regan A.W., Chupp G.L., Lowry J.A., Goetschkes M., Mulligan N., Berman J.S. Osteopontin is associated with T cells in sarcoid granulomas and has T cell adhesive and cytokine-like properties in vitro. Journal of Immunology. 162:1999;1024-1031.
52. O'Regan A.W., Hayden J.M., Berman J.S., Chupp G.L., Lowry J.A., Goetschkes M., Mulligan N. Osteopontin augments cd3-mediated interferon-gamma and CD40 ligand expression by T cells, which results in IL-12 production from peripheral blood mononuclear cells. Journal of Leukocyte Biology. 68:2000;495-502.
53. Puente Navazo M.D., Valmori D., Ruegg C. The alternatively spliced domain tnfniii a1a2 of the extracellular matrix protein tenascin-C suppresses activation-induced t lymphocyte proliferation and cytokine production. Journal of Immunology. 167:2001;6431-6440.
54. Reinhold M.I., Lindberg F.P., Kersh G.J., Allen P.M., Brown E.J. Costimulation of T cell activation by integrin-associated protein (CD47) is an adhesion-dependent, CD28-independent signaling pathway. Journal of Experimental Medicine. 185:1997;1-11.
55. Roberts D.D. Regulation of tumor growth and metastasis by thrombospondin-1a. FASEB Journal. 10:1996;1183-1191.
56. Rodrigues R.G., Guo N., Zhou L., Sipes J.M., Williams S.B., Templeton N.S., Gralnick H.R., Roberts D.D. Conformational regulation of the fibronectin binding and α3β1 integrin-mediated adhesive activities of thrombospondin-1. The Journal of Biology Chemistry. 276:2001;27913-27922.
57. Savino W., Mendes-da-Cruz D.A., Silva J.S., Dardenne M., Cotta-de-Almeida V. Intrathymic T cell migration: A combinatorial interplay of extracellular matrix and chemokines? Trends in Immunology. 23:2002;305-313.
58. Talts J.F., Wirl G., Dictor M., Muller W.J., Fassler R. Tenascin-C modulates tumor stroma and monocyte/macrophage recruitment but not tumor growth or metastasis in a mouse strain with spontaneous mammary cancer. Journal of Cell Science. 112(Pt 12):1999;1855-1864.
59. Ticchioni M., Deckert M., Mary F., Bernard G., Brown E.J., Bernard A. Integrin-associated protein (CD47) is a comitogenic molecule on CD3-activated human T cells. Journal of Immunology. 158:1997;677-684.
60. Ticchioni M., Raimondi V., Lamy L., Wijdenes J., Lindberg F.P., Brown E.J., Bernard A. Integrin-associated protein (CD47/IAP) contributes to T cell arrest on inflammatory vascular endothelium under flow. FASEB Journal. 15:2001;341-350.
61. Tsunoda T., Inada H., Kalembeyi I., Imanaka-Yoshida K., Sakakibara M., Okada R., Katsuta K., Sakakura T., Majima Y., Yoshida T. Involvement of large tenascin-C splice variants in breast cancer progression. American Journal of Pathology. 162:2003;1857-1867.
62. Vaday G.G., Franitza S., Schor H., Hecht I., Brill A., Cahalon L., Hershkoviz R., Lider O. Combinatorial signals by inflammatory cytokines and chemokines mediate leukocyte interactions with extracellular matrix. Journal of Leukocyte Biology. 69:2001;885-892.
63. Vallejo A.N., Mugge L.O., Klimiuk P.A., Weyand C.M., Goronzy J.J. Central role of thrombospondin-1 in the activation and clonal expansion of inflammatory T cells. Journal of Immunology. 164:2000;2947-2954.
64. Vallejo A.N., Yang H., Klimiuk P.A., Weyand C.M., Goronzy J.J. Synoviocyte-mediated expansion of inflammatory T cells in rheumatoid synovitis is dependent on CD47-thrombospondin 1 interaction. Journal of Immunology. 171:2003;1732-1740.
65. Wilson K.E., Li Z., Kara M., Gardner K.L., Roberts D.D. B1 integrin- and proteoglycan-mediated stimulation of t lymphoma cell adhesion and mitogen-activated protein kinase signaling by thrombospondin-1 and thrombospondin-1 peptides. Jounal of Immunology. 163:1999;3621-3628.
66. Woods M.L., Shimizu Y. Signaling networks regulating beta1 integrin-mediated adhesion of T lymphocytes to extracellular matrix. Journal of Leukocyte Biology. 69:2001;874-880.
67. Workalemahu G., Foerster M., Kroegel C., Braun R.K. Human gamma delta-T lymphocytes express and synthesize connective tissue growth factor: Effect of IL-15 and TGF-beta 1 and comparison with alpha beta-T lymphocytes. Journal of Immunology. 170:2003;153-157.
68. Yabkowitz R., Dixit V.M., Guo N., Roberts D.D., Shimizu Y. Activated T cell adhesion to thrombospondin is mediated by the α4ß1 (vla-4) and α5ß1 (vla-5) integrins. Journal of Immunology. 151:1993;149-158.
69. Yokasaki Y., Sheppard D. Mapping of the cryptic integrin-binding site in osteopontin suggests a new mechanism by which thrombin can regulate inflammation and tissue repair. Trends in Cardiovascular Medicine. 10:2000;155-159.